Floatz logo

Orsythia Component Ethinyl Estradiol

Infertility Disorder

Royan InstituteSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

25 Active assets in the Infertility Disorder cohort.

Asset / SponsorPhaseRating
CLOMIPHENE CITRATE
Sana'a University
Phase 4A
Metformin
Peking University Third Hospital
Phase 4A
Letrozole
GABRIEL MONTEIRO PINHEIRO
Phase 4BBB
Cetrotide
Fayoum University
Phase 4BBB
Human Chorionic Gonadotropin
Damascus University
Phase 4BBB

View all 43 →

Same molecule, other indications

Orsythia Component Ethinyl Estradiol is also rated in:

polycystic ovary syndromeActive
BBB
Indicative · Phase 4
75 / 100
View asset →
migraine disorderDormant
BB
Indicative · Phase 3
66 / 100
View asset →
chronic pain syndromeDormant
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →